Author Archives : Editorial Team

Home  >>  Author : Editorial Team

DKFZ: Breast cancer: How advanced imaging technologies will help avoid unnecessary biopsies

On February 21, 2018, Posted by , In News, With Comments Off on DKFZ: Breast cancer: How advanced imaging technologies will help avoid unnecessary biopsies

Enhancing the diagnosis of breast cancer is the stated goal of a research team at the German Cancer Research Center (DKFZ) in Heidelberg. The scientists have combined an advanced method of diffusion-weighted MR imaging with intelligent image analysis methods to detect malignant changes in tissues. This method may help avoid…

Heidelberg University: Intel and Researchers from Heidelberg and Dresden present three new neuromorphic chips

On February 20, 2018, Posted by , In Press Releases, With Comments Off on Heidelberg University: Intel and Researchers from Heidelberg and Dresden present three new neuromorphic chips

Researchers from Heidelberg University and TU Dresden, together with Intel Corporation, will reveal three new neuromorphic chips during the NICE Workshop 2018 in the USA. These chips have an extraordinary ability: They are able to mimic important aspects of biological brains by being energy efficient, resilient and able to learn….

DKFZ: European excellence grant for DKFZ researcher

On February 19, 2018, Posted by , In News, With Comments Off on DKFZ: European excellence grant for DKFZ researcher

The ERC Consolidator Grants by the European Research Council (ERC) support excellent researchers to help them consolidate their independent career. Ana Martin-Villalba from the German Cancer Research Center (DKFZ) has now received this prestigious ERC grant. Martin-Villalba will use the €2 million grant to investigate how repair processes can be…

Roche to acquire Flatiron Health to accelerate industry-wide development and delivery of breakthrough medicines for patients with cancer

On February 16, 2018, Posted by , In News, With Comments Off on Roche to acquire Flatiron Health to accelerate industry-wide development and delivery of breakthrough medicines for patients with cancer

Acquisition will bring together two companies committed to improving the lives of cancer patients through the evolving field of healthcare data and analytics The companies will leverage their combined expertise to advance the use of real-world evidence to set new industry standards for oncology research and development Flatiron Health to…

EMBL: Study identifies new diabetes genes

On February 15, 2018, Posted by , In News, With Comments Off on EMBL: Study identifies new diabetes genes

Scientists identify a network of genes that could play an important role in the development of diabetes Scientists used mice to identify 23 genes might play a role in human diabetes. PHOTO: EMBL-EBI/Spencer Phillips Researchers at the European Bioinformatics Institute (EMBL-EBI), with colleagues at the Helmholtz Center Munich and the…

DKFZ: “Lightning protectors” protect cells from oxidative damage

On February 15, 2018, Posted by , In News, With Comments Off on DKFZ: “Lightning protectors” protect cells from oxidative damage

Scientists from the German Cancer Research Center (DKFZ) have been able to unravel how acetylcysteine, a well-known agent used as a cough medication, can protect cells from oxidative stress. In the cell, the substance is rapidly transformed into so-called persulfides. These sulfur compounds unfold their protective effect on the cell…

Sciomics participates in collaborative clinical trials for the treatment of metaphyseal chondrodysplasia type Schmid (MCDS)

On February 12, 2018, Posted by , In News, With Comments Off on Sciomics participates in collaborative clinical trials for the treatment of metaphyseal chondrodysplasia type Schmid (MCDS)

Heidelberg, 12th February, 2018 Multinational consortium has been granted 5.7 Million Euro for the development of novel therapeutic approaches in rare skeletal disorders. Sciomics’ expertise with the antibody microarray technology herein serves as a valuable tool for biomarker identification and personalized treatment monitoring. The biotechnology company Sciomics GmbH, located in…

Slovakia becomes EMBL member state

On February 8, 2018, Posted by , In News, With Comments Off on Slovakia becomes EMBL member state

EMBL welcomes Slovakia as its 24th member state EMBL welcomed Slovakia as its latest member state on 29 January 2018. The accession of the Slovak Republic to EMBL emphasises the organisation’s commitment to promoting European science and collaboration among researchers. As a member state, Slovakia will receive access to all…

Two Excellent Young Researchers Honoured in Heidelberg

On February 8, 2018, Posted by , In News, With Comments Off on Two Excellent Young Researchers Honoured in Heidelberg

Marieke Essers and Theodore Alexandrov have received Chica and Heinz Schaller Award for basic biomedical research Photo: Rothe Chica und Heinz Schaller Award for basic biomedical research: Dr Marieke Essers (second from right) and Dr Theodore Alexandrov (centre) receiving the award. The award was handed over by the foundation’s Chairperson,…

Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas

On February 8, 2018, Posted by , In News, With Comments Off on Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas

Heidelberg, Germany, February 1, 2018 – Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today reported additional preliminary patient data from two separate clinical studies of its lead NK cell engager candidate AFM13. The data demonstrate that AFM13 was well-tolerated…